Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery Health Condition 2: null- Coronary Artery Disease
Conditions
Interventions
None listed
Sponsors
Terumo India Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: .Patient is above or equal to 18 years old .Patient is eligible for percutaneous coronary intervention using DES as per hospital routine .Patient agrees to provide written informed consent as approved by IRB or IEC
Exclusion criteria
Exclusion criteria: .The patients with lesion characteristics not suitable for the treatment with Ultimaster DES will not be enrolled .Patient not willing to provide written informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Target Lesion Failure (TLF) defined as a composite of cardiac death, target vessel related myocardial infarction (MI) and clinically driven target lesion revascularization (TLR) at 1 yearTimepoint: 1 year post index procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| Success endpoints .Procedural Success .Device Success Safety endpoints .Cardiac Death/MI (peri & post procedural) .Stent Thrombosis .Major Vascular & bleeding complications Efficacy and patient oriented (composite) endpoints .Target Lesion Revascularization Rate .Target Vessel Failure Rate .Patient Oriented Composite Endpoint defined as any cause of mortality, MI or any TVRTimepoint: At 3 months and 1 year post index procedure | — |
Countries
India
Contacts
Public ContactDr Sandeep Arora
Outcome results
None listed